FocalTherics

FOCL Healthcare Medical Distribution

Revenue
+38.9%
EPS
−129.4%
Free cash flow
+21.5%
Total debt
+366.8%

Quarter to June 2026, against a year earlier

3.87 0.38 −8.94%
Market cap
$159.3M
P/E
0.0×
Fwd P/E
−3.7×
Dividend yield
—
F-score
3/9
Altman Z
−0.87
Beneish M
−3.14
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

0.00% (61.02%) (83.79%) (133.48%)
Piotroski F-Score
4 3 3 4
ROA
(27.10%) (34.73%) (40.37%) (50.28%)
ROIC
(64.11%) (71.99%) (81.16%) (110.75%)
Return on Tangible Assets
(80.56%) (101.51%) (133.93%) (126.51%)
Average Days of Receivables
131.89 84.02 100.17 50.27
Free Cash Flow per Share
(0.48) (0.62) (0.56) (0.51)
Free Cash Flow
(17.79) (23.19) (20.87) (19.13)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026